Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CSPG5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | YTHDF1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | GGCT | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GGA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TFDP1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | PANK1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ITFG1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | ABLIM3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CSTF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | DUSP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |